CAS号 | 名称 | 物化性质 | 分子式 | 分子量 |
1352827-50-9 | n-methylated pomalidomide | |
C14H13N3O4 | 287.27 |
1344198-24-8 | n-methyl{5-[2-(methylsulfanyl)ethyl]-1,3,4-oxadiazol-2-yl}methanamine | |
| |
1224049-73-3 | n-ethyl-n-methyl-3-(3-pyrrolidinyl)benzamide | |
| |
1001754-56-8 | n-ethyl-5-(methylsulfonyl)-4-(3-piperidinyl)-2-pyrimidinamine | |
| |
1263281-16-8 | n-ethyl-5-(3-methyl-5-isoxazolyl)-4-(4-piperidinyl)-2-pyrimidinamine | |
| |
1001754-39-7 | n-ethyl-5-(3-methyl-5-isoxazolyl)-4-(3-piperidinyl)-2-pyrimidinamine | |
| |
1369494-24-5 | n-ethyl-4-(4-piperidinylmethyl)-2-pyrimidinamine | |
| |
1263282-23-0 | n-cyclopropyl-4-(3-piperidinylmethyl)-2-pyrimidinamine | |
| |
219783-77-4 | n-cinnamoyl-n-debenzoylpaclitaxel | 熔点:149-150 °C 沸点:982.1±65.0°C at 760 mmHg
|
C49H53NO14 | 879.94 |
2081100-00-5 | n-(but-3-yn-1-yl)-4-hydrazineylbenzamide hydrochloride | |
| |
1016871-13-8 | n-(4-fluorobenzyl)-2-(methylamino)acetamide | |
| |
101739-55-3 | n-(4-acetylphenyl)-n′-octylthiourea
| |
| |
1568595-45-8 | n-(4-(ethylcarbamoyl)phenyl)pyrrolidine-2-carboxamide hydrochloride | |
| |
1795133-97-9 | n-(2-hydroxy-5-(1-hydroxy-2-{[1-(4-methoxyphenyl)propan-2-yl](methyl)amino}ethyl)phenyl)formamide fumarate | |
| |
90031-88-2 | n-(2-bromoethyl)-4-[(e)-dibenzo[b,d]furan-3-yldiazenyl]-1-naphthalenamine | |
| |
22892-60-0 | n-(2-benzoyl-4-chlorophenyl)-n-methylbenzamide | |
| |
1259396-88-7 | n-(2-(tert-butoxy)-2-oxoethyl)-n-ethylglycine | |
| |
794535-49-2 | n-(2-[1,1′-biphenyl]-4-yl-2-oxoethyl)-2,2-dichloroacetamide
| |
| |
106454-50-6 | n-(2-{[(benzyloxy)carbonyl]amino}-3-phenylpropanoyl)phenylalanine | |
| |
73323-67-8 | n-(1-methyl-2-oxoethyl)acetamide | |
| |
2079094-19-0 | n-((s)-1-((s)-4-苄基-4,5-二氢恶唑-2-基)-2,2-二甲基丙基)乙酰胺 n-((s)-1-((s)-4-benzyl-4,5-dihydrooxazol-2-yl)-2,2-dimethylpropyl)acetamide | |
| |
2079094-32-7 | n-((s)-1-((4s,5s)-4-benzyl-5-phenyl-4,5-dihydrooxazol-2-yl)-2,2-dimethylpropyl)acetamide | |
| |
2083655-63-2 | n-((1s,2s)-1-((r)-4-isobutyl-4,5-dihydrooxazol-2-yl)-2-methylbutyl)acetamide | |
| |
207570-27-2 | n-[5-(methylamino)-6-oxo-1,4,5,6-tetrahydro-2-pyrimidinyl]urea | |
| |
872306-90-6 | n-{4-[(4-nitrophenyl)sulfonyl]phenyl}heptanamide | |
| |
1094755-55-1 | n-[2-(4-methoxyphenyl)ethyl]hydrazinecarboxamide | |
| |
1094561-51-9 | n-[2-(2-fluorophenyl)ethyl]hydrazinecarboxamide | |
| |
21756-77-4 | n-{1-[4-(4-fluorophenyl)-4-oxobutyl]-3-pyrrolidinyl}-n-phenylpropanamide | |
| |
1179992-99-4 | moxifloxacin related compound f | |
C22H26FN3O4 | 415.46 |
863767-83-3 | molybdenum disulfide quantum dots | |
| |
1356841-17-2 | moexipril related compound g | |
| |
1356019-89-0 | moexipril related compound d | |
| |
103733-40-0 | moexipril related compound c | 熔点:148-150 °C
|
C35H46N2O11 | 670.76 |
118779-53-6 | modafinil sulfone | |
| |
223472-31-9 | mmp inhibitor v-cas 223472-31-9-calbiochem | |
| |
432531-71-0 | mlkl抑制剂,坏死磺酰胺-cas 432531-71-0-calbiochem mlkl inhibitor, necrosulfonamide-cas 432531-71-0-calbiochem | |
C18H15N5O6S2 | 461.47 |
1802907-92-1 | methyltetrazine-peg4-nhs ester | |
C24H31N5O9 | 533.54 |
91523-05-6 | 17,21-dihydroxy-6α-methylpregna-1,4-diene-3,11,20-trione methylprednisolone related compound a | |
| |
955886-82-5 | methyl 7-hydroxy-3h-1l3-benzo[d]oxazole-5-carboxylate | |
| |
1141417-81-3 | methyl 6,7,8,9-tetrahydro-5h-pyridazino[3,4-d]azepin-3-yl ether | |
| |
893734-98-0 | methyl 5-(3-formylphenyl)nicotinate | |
| |
150437-96-0 | methyl 4-amino-2-propyl-1h-imidazole-5-carboxylate | |
| |
1196047-14-9 | methyl 4-(aminomethyl)-3-methylbenzoate hydrochloride | |
| |
1001754-99-9 | methyl 3-methyl-2-oxo-2,3-dihydro-1h-imidazo[4,5-b]pyridine-6-carboxylate | |
| |
34815-23-1 | methyl 3-(chloromethyl)-4-methylbenzoate | |
| |
1263283-36-8 | methyl 2-chloro-6-fluoro-3-formylbenzoate | |
| |
874183-37-6 | methyl [2-bromo-4′-(trifluoromethyl)[1,1′-biphenyl]-4-yl]acetate
| |
| |
441717-79-9 | methyl 2-(4-amino-5-chloro-2-fluorophenyl)acetate | |
| |
1012312-63-8 | methyl 2-(3-formylphenyl)propanoate | |
| |
20896-25-7 | methyl 1,3-dihydrobenzo[c]thiophene-5-carboxylate | |
| |